Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function

被引:17
|
作者
Iommarini, Luisa [1 ]
Peralta, Susana [2 ]
Torraco, Alessandra [3 ]
Diaz, Francisca [2 ]
机构
[1] Univ Bologna, Dept Pharm & Biotechnol FABIT, I-40128 Bologna, Italy
[2] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA
[3] IRCCS, Bambino Gesu Childrens Hosp, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, I-00146 Rome, Italy
关键词
Mitochondrial DNA; Mitochondrial transcription; Mouse models; Mitochondrial dynamics; Quality control; Mitochondrial diseases; ADENINE-NUCLEOTIDE TRANSLOCATOR; THYMIDINE KINASE 2; DOMINANT OPTIC ATROPHY; M-AAA PROTEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RESPIRATORY-CHAIN DEFICIENCY; IMPAIRED INSULIN-SECRETION; APOPTOSIS-INDUCING FACTOR; MULTIPLE MTDNA DELETIONS; DNA DEPLETION SYNDROME;
D O I
10.1016/j.mito.2015.01.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mitochondrial disorders are defined as defects that affect the oxidative phosphotylation system (OXPHOS). They are characterized by a heterogeneous array of clinical presentations due in part to a wide variety of factors required for proper function of the components of the OXPHOS system. There is no cure for these disorders owing to our poor knowledge of the pathogenic mechanisms of disease. To understand the mechanisms of human disease numerous mouse models have been developed in recent years. Here we summarize the features of several mouse models of mitochondrial diseases directly related to those factors affecting mtDNA maintenance, replication, transcription, translation as well as other proteins that are involved in mitochondrial dynamics and quality control which affect mitochondrial OXPHOS function without being intrinsic components of the system. We discuss how these models have contributed to our understanding of mitochondrial diseases and their pathogenic mechanisms. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:96 / 118
页数:23
相关论文
共 5 条
  • [1] Mitochondrial Diseases Part I: Mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors
    Torraco, Alessandra
    Peralta, Susana
    Iommarini, Luisa
    Diaz, Francisca
    [J]. MITOCHONDRION, 2015, 21 : 76 - 91
  • [2] Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies
    Peralta, Susana
    Torraco, Alessandra
    Iommarini, Luisa
    Diaz, Francisca
    [J]. MITOCHONDRION, 2015, 23 : 71 - 80
  • [3] Mouse models of oxidative phosphorylation defects: Powerful tools to study the pathobiology of mitochondrial diseases
    Torraco, Alessandra
    Diaz, Francisca
    Vempati, Uma D.
    Moraes, Carlos T.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (01): : 171 - 180
  • [4] Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
    Fernandez-Checa, J. C.
    Fernandez, A.
    Morales, A.
    Mari, M.
    Garcia-Ruiz, C.
    Colell, A.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 439 - 454
  • [5] Adipose gene expression regulating-mitochondrial function is down-regulated in two mouse models of obesity and type II diabetes and improved by rosiglitazone
    Rong, James X.
    Qiu, Yang
    Hansen, Michael K.
    Zhu, Lei
    Zhang, Vivian
    Ryan, Terence E.
    [J]. DIABETES, 2006, 55 : A316 - A316